Journal article
Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke Outcomes.
Abstract
BACKGROUND: Infarct volume is an imaging biomarker of ischemic tissue injury strongly correlated with poststroke outcomes and reperfusion benefit. We aimed to evaluate the follow-up infarct volume (FIV) difference corresponding to a 1%, 5%, and 10% increase in probability of excellent functional outcomes after intravenous thrombolysis.
METHODS: Data are from the AcT trial (Alteplase Compared to Tenecteplase in Patients With Acute Ischemic …
Authors
Pensato U; Ospel JM; Zhang J; Barakhanov K; Tanaka K; Bala F; Kaveeta C; Kim D; Shamy M; Horn M
Journal
Journal of the American Heart Association, , ,
Publisher
Wolters Kluwer
Publication Date
October 23, 2025
DOI
10.1161/jaha.125.044246
ISSN
2047-9980
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
HumansFemaleMaleAgedMiddle AgedAged, 80 and overIschemic StrokeFibrinolytic AgentsTissue Plasminogen ActivatorTreatment OutcomeMinimal Clinically Important DifferenceThrombolytic TherapyMagnetic Resonance ImagingTomography, X-Ray ComputedTenecteplaseThrombectomyEndovascular ProceduresStrokeRecovery of Function